证券日报网讯悦心健康（002162）8月1日在互动平台回答投资者提问时表示，截至2025年7月31日，公 司股东总户数65746户，机构总户数2145户。 ...

Group 1 - The company's stock closed at 4.40 yuan on July 29, down 0.12 yuan or 2.65% from the previous trading day [1] - The stock opened at 4.59 yuan, reached a high of 4.79 yuan, and a low of 4.36 yuan, with a trading range of 9.51% [1] - The total trading volume for the day was 720,205 hands, with a transaction amount of 325 million yuan and a turnover rate of 7.84% [1] Group 2 - The company operates in the health industry, with main products including tiles and negative ion health materials, as well as services in medical care and health management [1] - The company is registered in Shanghai and has a business scope that covers building materials manufacturing and medical services [1] Group 3 - During the morning session on July 29, the company's stock experienced a rapid decline, with a drop of over 2% within the first five minutes before 9:35 AM, and a transaction amount of 103 million yuan at that time [1] - The net outflow of main funds for the day was 14.647 million yuan, accounting for 0.36% of the circulating market value [1]

Core Viewpoint - The company has completed changes to its registered capital and corporate governance structure, including the cancellation of the supervisory board and amendments to its articles of association [2][3]. Group 1: Capital Changes - The company approved a stock option incentive plan, resulting in the exercise of 2,106,665 shares, increasing the total share capital from 920,000,000 shares to 922,106,665 shares [2]. - Following a share buyback of 2,405,700 shares, the total share capital was reduced to 919,700,965 shares, and the registered capital was adjusted accordingly [2][3]. - The company has completed the registration procedures for the changes in registered capital with the Shanghai Municipal Market Supervision Administration [3]. Group 2: Corporate Governance - The company held meetings to approve the cancellation of the supervisory board and the revision of its articles of association [2]. - The changes in corporate governance were officially recorded and the new business license was issued [3].

证券代码：002162 证券简称：悦心健康 公告编号：2025-050 二○二五年七月十八日 1 特此公告。 上海悦心健康集团股份有限公司 董事会 关于完成注册资本工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，不存在虚假 记载、误导性陈述或者重大遗漏。 上海悦心健康集团股份有限公司（以下简称"公司"）分别于 2025 年 5 月 26 日、2025 年 6 月 11 日召开了第八届董事会第十五次会议、2025 年第一次临时股东 大会，审议通过了《关于变更注册资本、取消监事会暨修订<公司章程>及其附件的议 案》。公司 2023 年股票期权激励计划首次授予部分股票期权第一个行权期内（2024 年 5 月 20 日至 2025 年 5 月 16 日），公司激励对象累计行权 2,106,665 股，公司总 股本由 920,000,000 股增加至 922,106,665 股，公司注册资本相应由人民币 920,000,000 元增加至人民币 922,106,665 元。同时，2025 年 5 月 13 日，公司实施 完毕股份回购事项，累计回购公司股份 2,405,700 股，并于 202 ...

Core Viewpoint - Shanghai Yueshen Health Group plans to use surplus reserves of 72.85 million yuan and capital reserves of 141 million yuan, totaling 214 million yuan, to offset cumulative losses, resulting in a significant reduction of its reserves and a nearly 400% drop in net profit for 2024 [1][2][4]. Financial Summary - For 2024, the company reported revenue of 1.204 billion yuan, a year-on-year decrease of 5.79%, and a net profit attributable to shareholders of -147 million yuan, a staggering decline of 393.87% [4]. - The company has experienced negative net profits for three consecutive years, with cumulative losses exceeding 500 million yuan, indicating concerns over its core business's ability to generate profits [4]. - The company's operating cash flow also decreased by 33.48% year-on-year, amounting to 82.23 million yuan [4]. Business Transformation - Yueshen Health, originally focused on ceramic tiles, has been transitioning into the health sector since 2015, with its business now encompassing building materials, health services, and investment property leasing [5]. - The company’s building materials segment primarily focuses on high-end ceramic tile brand "Simik," while its health services include various care systems and training programs [5]. Loss Factors - The primary reasons for the company's losses include a decline in revenue from the ceramic tile business due to reduced market demand, increased competition, and rising costs [3]. - The company has also faced challenges related to the long investment cycle of its health projects and asset impairment losses, which have further exacerbated its financial difficulties [4].

Core Viewpoint - Shanghai Yueshen Health Group Co., Ltd. plans to use surplus reserves to cover losses, as the company reported a significant decline in net profit due to increased market competition and reduced sales prices of its products [1][2]. Group 1: Financial Adjustments - The company intends to utilize a total of 72,853,943.26 yuan from surplus reserves and 141,057,228.79 yuan from capital reserves to offset losses, resulting in a reduction of capital reserves to 176,595,527.02 yuan [1]. - As of December 31, 2024, the company's undistributed profits were reported at -0 yuan, indicating a complete depletion of retained earnings [1]. Group 2: Causes of Loss - The primary reasons for the company's losses include a slight decline in sales and intensified market competition, which led to a decrease in sales prices and gross margins of tile products [2]. - The company has also recognized potential impairment losses on assets, further exacerbating the cumulative loss [2]. Group 3: Notification to Creditors - The company has formally notified creditors of their rights to claim debts or request guarantees within 30 days of receiving the notice, or 45 days from the announcement date if no notice is received [2][3]. - Creditors must submit written requests along with relevant documentation to the company to assert their claims [2][3].

证券代码：002162 证券简称：悦心健康 公告编号：2025-049 上海悦心健康集团股份有限公司 关于使用公积金弥补亏损通知债权人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、通知债权人的原由 上海悦心健康集团股份有限公司（以下简称"公司"）分别于2025年5月26日、2025 年6月11日召开了第八届董事会第十五次会议、2025年第一次临时股东大会，审议通过 了《关于公司使用公积金弥补亏损的议案》。根据信永中和会计师事务所（特殊普通 合伙）出具的审计报告，截至2024年12月31日，公司母公司报表未分配利润为- 452,167,917.70元，盈余公积为72,853,943.26元，资本公积为317,652,755.81元。为 贯彻落实中国证监会《关于加强上市公司监管的意见（试行）》等法律法规要求，提升 股东回报能力，根据《公司法》、财政部《关于公司法、外商投资法施行后有关财务处 理问题的通知》（财资〔2025〕101号）及《公司章程》等相关规定，公司拟使用母公司 盈余公积金 72,853,943.26 元和资本公积金 141,057, ...

Group 1 - The childcare service concept sector rose by 1.82%, leading the concept sectors in terms of growth, with 13 stocks increasing in value [1][2] - Notable gainers in the sector included Huamei Holdings, which hit the daily limit, and other companies like Dou Shen Education, Hejing Technology, and Chuangyuan Co., which rose by 5.98%, 5.55%, and 4.21% respectively [1][2] - The sector experienced a net outflow of 243 million yuan in main funds, with Dou Shen Education receiving the highest net inflow of 69.37 million yuan [2][3] Group 2 - The top three stocks in terms of net inflow ratio were Chuangyuan Co. at 4.71%, Huamei Holdings at 3.96%, and Zhongyuan Media at 3.49% [3] - Stocks with significant declines included Tuo Wei Information, *ST Jinke, and Yuexin Health, which fell by 1.42%, 1.34%, and 1.15% respectively [1][2] - The overall market showed mixed performance, with various sectors experiencing both gains and losses, highlighting the volatility in the current investment landscape [2][4]

Group 1 - The core viewpoint of the articles highlights the strategic partnership between Yueshin Health's subsidiary Yueshin Duobao and Jinyi Robotics, marking a shift from research collaboration to substantial commercial cooperation [1][2] - The joint venture will focus on the research, production, and sales of robots applicable to the medical rehabilitation and elderly care sectors, enhancing Yueshin Duobao's strategic layout in the healthcare field [1] - Jinyi Robotics, founded in 2016, is a pioneer in the intelligent rehabilitation robot sector, boasting 23 invention patents, 20 utility model patents, 8 design patents, 12 software copyrights, and 30 trademarks, with products including lower limb rehabilitation robots and cognitive training robots [1] Group 2 - The collaboration is seen as a recognition of each other's technological strength and market potential, as well as a deep insight into the future development trends of the medical rehabilitation industry [2] - The partnership aims to promote the in-depth application of artificial intelligence technology in the medical rehabilitation field, improving the quality and efficiency of rehabilitation services [2] - With ongoing technological advancements, rehabilitation robots are expected to be increasingly utilized in nursing homes, medical institutions, communities, and households, significantly enhancing patient rehabilitation experiences [2]

证券代码：002162 证券简称：悦心健康 公告编号：2025-048 特此公告。 上海悦心健康集团股份有限公司 董事会 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 上海悦心健康集团股份有限公司（以下简称"公司"）分别于 2025 年 5 月 26 日、 2025 年 6 月 11 日召开第八届董事会第十五次会议、2025 年第一次临时股东大会，审议 通过了《关于变更注册资本、取消监事会暨修订<公司章程>及其附件的议案》，根据《公 司法》及《上市公司章程指引》等法律法规的规定，公司修订了《公司章程》，取消了监 事会设置，《公司监事会议事规则》等监事会相关制度相应废止，公司各项制度中涉及 监事会、监事的规定不再适用。监事任保强先生、尹竣先生、林琦女士因公司治理结构 调整，担任的第八届监事会监事职务自然免除。离任监事后，林琦女士仍在公司任职， 任保强先生、尹竣先生不在公司担任职务。 根据《公司法》相关规定，公司在前述的《公司章程》修订中规定了由董事会审计 委员会承接监事会相关职责。本次监事离任后，公司治理结构符合《公司法》关于"不 设监事会或监事"的要求，不 ...